UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
13 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
UBS Q2 Preview on U.S. Pharmaceuticals: Safe Havens in Generic, Specialty and Large-Cap
Analyst, Marc Goodman, likes Watson (NYSE: WPI) and Mylan (NYSE: MYL) in the generic space, citing upside from Actavis, the Lidoderm settlement, Adderall XR approval and Vancocin.
In Specialty Pharma, favored stocks include Allergan Inc. (NYSE: AGN), Endo Health Solutions Inc. (Nasdaq: ENDP), Valeant Pharmaceuticals (NYSE: VRX), and Warner Chilcott plc (Nasdaq: WCRX).
Large-Cap favorites include Pfizer (NYSE: PFE) and Merck (NYSE: MRK), citing expected Tofa approval and Suvorexant data set was encouraging.
Analyst, Marc Goodman, likes Watson (NYSE: WPI) and Mylan (NYSE: MYL) in the generic space, citing upside from Actavis, the Lidoderm settlement, Adderall XR approval and Vancocin.
In Specialty Pharma, favored stocks include Allergan Inc. (NYSE: AGN), Endo Health Solutions Inc. (Nasdaq: ENDP), Valeant Pharmaceuticals (NYSE: VRX), and Warner Chilcott plc (Nasdaq: WCRX).
Large-Cap favorites include Pfizer (NYSE: PFE) and Merck (NYSE: MRK), citing expected Tofa approval and Suvorexant data set was encouraging.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- DA Davidson Starts Comfort Systems USA (FIX) at Buy
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
